S

Stereotaxis
D

STXS

2.01500
USD
0.09
(4.40%)
Post Trading
Volume
7
EPS
0
Div Yield
0
P/E
-8
Market Cap
170,582,352
OverviewSignalsIdeasNews
Related Instruments
    ABT
    4.220
    (3.98%)
    110.150 USD
    A
    ALGN
    -3.810
    (-1.64%)
    228.270 USD
    B
    BAX
    0.190
    (0.53%)
    36.000 USD
    DXCM
    2.510
    (3.70%)
    70.340 USD
    EW
    -1.220
    (-1.94%)
    61.830 USD
    ISRG
    6.98
    (1.57%)
    451.27 USD
    MDT
    0.160
    (0.20%)
    80.470 USD
    SYK
    5.59
    (1.71%)
    332.94 USD
    TMO
    9.03
    (1.47%)
    621.78 USD
    Z
    ZBH
    -0.280
    (-0.25%)
    111.100 USD
News

Title: Stereotaxis

Sector: Healthcare
Industry: Medical Instruments & Supplies
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, andinformation solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States.